Will Positive Speculation Help Marijuana Stocks In 2025?

Can This Relentless Stock Join Taiwan Semiconductor and Berkshire Hathaway In the $1 Trillion Club?

AI To Propel Snowflake Stock Higher

Vaalco Energy: Get A 6.7% Yield With 150% Growth

When Market Pain Means Income Investor Gain

WIW: 8%-Plus Yield, 11% Discounted Inflation Protection

ECB: Gold Now Second Only to USD in Global Reserves

New Nubz Chew Treats from Nylabone Add a Burst of Flavor to the Dog Days of Summer

Shopify's Dip Buying Opportunity May Be Coming

Silicon Motion: Positioned For Recovery And Sustainable Growth

Hycroft Mining: Gold Miner With A Lottery Ticket Profile

The Inflation That Wasn't

These 2 Nvidia Partners Will Power the Next Generation of Data Centers

S&P Global Strengthens Its Core With Strategic Spin-Off And AI Focus

ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN

Should You Buy Ford While It's Below $11?

Gold (XAUUSD) Price Forecast: Will Fed Dovishness and Mideast Tensions Trigger a Record Gold Rally?

S&P Global: Dividend Aristocrat Without Being A Value-Style Stock

Blue Bird Still Looks Cheap For A Stock With This Much Visibility

Gilead Sciences: Strong Buy On Pipeline Momentum And Cost Discipline

Costco to open new stand-alone gas station

AbbVie: A Biotech Powerhouse Generating Explosive EPS And Dividend Growth

Top Wall Street analysts suggest these dividend stocks for stable income

Block: Darkest Before Dawn For My Top Pick

TSMC Reports Another 40% YoY Revenue Growth In May, Resisting Tariff Fears

Lost Money on Reckitt Benckiser Group plc (RBGLY)? Contact Levi & Korsinsky Before August 4, 2025 to Join Class Action

Levi & Korsinsky Urges Rocket Companies (RKT) Shareholders to Act Before Lead Plaintiff Deadline July 8, 2025

Is Voyager Technologies Stock a Buy After Its Blockbuster IPO?

Lost Money on Krispy Kreme, Inc. (DNUT)? Urged to Join Class Action Before July 15, 2025 - Contact Levi & Korsinsky

Whitehaven Coal: A Growing Coal Miner With A Potential Trading Opportunity Around The Corner

Starbucks moves to the next phase in its turnaround: Winning over employees

USA: Nearly 9% Income, Narrow Discount And Decent Long-Term Performance

Did You Lose Money on Rocket Pharmaceuticals, Inc. (RCKT)? Levi & Korsinsky Urges Investors to Act Before August 11, 2025

Levi & Korsinsky Urges PepGen Inc. (PEPG) Shareholders to Act Before Lead Plaintiff Deadline August 8, 2025

Backblaze Investor News: If You Have Suffered Losses in Backblaze, Inc. (NASDAQ: BLZE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

2 Must-Own 6-11% Yields At Bargain Prices

Micron Q3 Preview: I Predicted This Surge, And It's Not Too Late

ACP: Don't Be Fooled By The High Yield; Consider These Alternatives Instead

RH Stock Rockets on Surprise Profit and Tariff Shift

Vestis Corporation (VSTS) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before August 8, 2025

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

HCI Vs American Coastal Insurance: HCI Continues To Be Undervalued Despite A Solid Rally

CEF Weekly Review: Loan CEF Valuations Deflating With Rates

Global X Uranium ETF Offers A Broader Investment Option In The Surging Nuclear Power Sector

Did You Lose Money on Ibotta, Inc. (IBTA)? Levi & Korsinsky Urges Investors to Act Before June 16, 2025

Investor Alert: Deadline Approaching to Join Red Cat Holdings, Inc. (RCAT) Class Action - Contact Levi & Korsinsky

Shopify Can Easily Cross $150B+ Market Cap In H2 2025

Class Action Alert: Levi & Korsinsky Reminds Bitfarms Ltd. (BITF) Investors of July 8, 2025 Deadline

Open Lending Corporation (LPRO) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of June 30, 2025 Deadline

AbbVie's Post-Humira Strategy Is Paying Off For Investors

Russian air attack damaged Boeing offices in Ukraine, FT reports

Voyager Technologies: Not Joining On The Mission

Aston Martin CEO on Tariffs, Le Mans, New Hypercar

FINAL ZBIO DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Zenas BioPharma, Inc. Investors to Join the Class Action Lawsuit

LPRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Open Lending Corporation Investors Have Opportunity to Lead Class Action Lawsuit!

DNUT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Krispy Kreme, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

RKT Shareholders Have Opportunity to Lead Rocket Companies, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!

DV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DoubleVerify Holdings, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

PEPG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

OGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Investors Have Opportunity to Lead Class Action Lawsuit!

DMRC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Digimarc Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

RCKT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Time To Buy These 3 Super SWANs

BITF STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bitfarms Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

RCAT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Red Cat Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

FTRE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Fortrea Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NPWR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of NET Power Inc. to Contact the Firm Today!

Ellington Financial: Little Impact On Book Value From April Volatility Expected

Lost Money on Fortrea Holdings Inc. (FTRE)? Urged to Join Class Action Before August 1, 2025 - Contact Levi & Korsinsky

Can a $10,000 Investment in CRISPR Therapeutics Turn Into $1 Million?

These 2 Beaten-Down Dividend Stocks and This ETF Yield Over 4%. Here's Why They Are Worth Doubling Up on in June.

Mediobanca weighs postponing Monday's investor vote on Banca Generali, source says

Better EV Stock: BYD vs. Tesla

Warren Buffett Has $90 Billion Invested in These 9 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch.

3 Monster Stocks to Confidently Own for the Next 10 Years

3 Reasons Why This Beaten-Down Growth Stock Could Trounce the S&P 500 in the Second Half of 2025

Here's How Many Shares of Apple Stock You Should Own to Get $1,000 in Yearly Dividends

The Smartest Tech ETF to Buy With $1,000 Right Now

M&T Bank Is Now A Modest Buy At Current Valuation And Earnings Potential

JD.com: Another Strong Buy From China

Kesko Oyj: A Hidden Nordic Retail Giant At A Very Reasonable Valuation

Is the Artificial Intelligence Boost Fading for This Top Tech Stock?

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

JFR: Income Now, Price Recovery Later

ZIM Integrated Shipping: Israel's 17% Yielder Just Got More Appealing

The Fundamental Problem With MicroStrategy's Bitcoin-Buying Plan

2 Artificial Intelligence (AI) Cloud Stocks to Buy in June

Warren Buffett Says Buy This Index Fund. It Could Turn $400 Per Month Into $851,800 With Help From Apple, Nvidia, and Tesla.

2 Reasons to Buy Costco Stock Like There's No Tomorrow

SCHO: The Case For Rotating Out Of Short-Duration Treasuries

1 Top Vanguard ETF That Could Turn $50,000 Into $542,000 in 25 Years

My 5 Favorite Stocks to Buy Right Now

ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade)

Prediction: This Red-Hot Growth Stock Will Continue Soaring in the Second Half of 2025

Where Will Roku Stock Be in 1 Year?

Boeing Dreamliner crash, military escalations darken mood at Paris Air Show

Eve Air Mobility and Revo Accelerate Urban Air Mobility with $250M Contract

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)